News

Published on 1 Jun 2024 on Simply Wall St. via Yahoo Finance

Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly


Article preview image

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Merck & Co., Inc. (NYSE:MRK) does use debt in its business. But should shareholders be worried about its use of debt?

Why Does Debt Bring Risk?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. When we examine debt levels, we first consider both cash and debt levels, together.

NYSE.MRK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Merck earnings top estimates amid solid demand for Keytruda cancer drug By...

Merck and Co. (NYSE:MRK) has posted better-than-anticipated third-quarter profit thanks to solid...

Investing.com 31 Oct 2024

Will Merck's Guidance Cut Prove Gruesome For Shares?

The company also reported light sales of HPV vaccine Gardasil and diabetes meds Januvia/Janumet.

Investor's Business Daily 31 Oct 2024

Merck’s Q3 earnings beat estimates, but company lowers guidance

Merck’s stock swung between gains and losses in premarket action.

Market Watch 31 Oct 2024

Merck Narrows Sales Outlook With Gardasil Shot Lagging in China

Merck & Co. lowered the top end of its full-year sales guidance after demand for its HPV vaccine...

Bloomberg 31 Oct 2024

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as...

Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations a...

CNBC 31 Oct 2024

Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’s Substack by ...

Insider Monkey · via Yahoo Finance 30 Oct 2024

Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 20 Stocks to Watch. In this...

Insider Monkey · via Yahoo Finance 30 Oct 2024

Snow probes adapted to improve pharmaceutical manufacturing | Cornell Chronicle

Louge, professor emeritus of mechanical and aerospace engineering, credits the boulder with...

Cornell News Service 29 Oct 2024

Analysts hail Vera's kidney drug as potential 'functional cure' as benefits...

Vera Therapeutics has shown the effect of atacicept on kidney function in patients with...

FierceBiotech 28 Oct 2024

Why Is Moderna Stock Trading Higher On Monday?

On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of ...

Benzinga · via Yahoo Finance 28 Oct 2024